Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel
Sponsor: Bristol-Myers Squibb